Shareholding disclosure

Kuros Biosciences AG

Collectively declared rate

7.8%

Threshold

Crossed upwards

Timeline

Published

23.01.2016

Transaction

22.01.2016

Voting rights breakdown

Voting rights acquired7.8%
Voting rights sold0%
Below threshold0%

Declared beneficial owners · 3

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

TBG1M00032

Beneficial owner

Otello Stampacchia

Declared address

Otello Stampacchia, Boston, MA

The purchase positions of the respective shareholder or group of shareholders (as applicable) which arose on December 1, 2015, as a result of such shareholder or group of shareholder having undertaken to exchange shares in Kuros Biosurgery Holding AG against New Shares at the closing of the Combination, which have been disclosed via the database maintained by SIX Swiss Exchange, have lapsed as a result of the Combination. Messrs. Otello Stampacchia, Boston, MA, USA, Richard Lim, Boston, MA, USA, and Ms. Anne-Mari Paster, Lexington, MA, USA, control the exercise of voting rights in the shares held by Omega Fund IV LP, a multi-investor fund.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open